Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pegylated Liposomal Doxorubicin|DRUG: Albumin-bound paclitaxel|DRUG: Trastuzumab
Sponsor: Peking Union Medical College
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.